Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)-Reference-Cited by-同舟云学术

Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)

Published:2017-09 Issue: Volume:111 Page:23-29
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Labbé Catherine,Cabanero Michael,Korpanty Grzegorz J.,Tomasini Pascale,Doherty Mark K.,Mascaux Céline,Jao Kevin,Pitcher Bethany,Wang Rick,Pintilie Melania,Leighl Natasha B.,Feld Ronald,Liu Geoffrey,Bradbury Penelope Ann,Kamel-Reid Suzanne,Tsao Ming-Sound,Shepherd Frances A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Uncovering the role of p53 splice variants in human malignancy: a clinical perspective;Surget;Onco Targets Ther.,2013

2. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer;Olivier;Clin. Cancer Res.,2006

3. TP53 mutations and survival in squamous-cell carcinoma of the head and neck;Poeta;N. Engl. J. Med.,2007

4. TP53 mutations in non-small cell lung cancer;Mogi;J. Biomed. Biotechnol.,2011

5. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes;Petitjean;Oncogene,2007

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dual biomarker in non-small cell lung cancer that predicts Li Fraumeni syndrome;Familial Cancer;2024-09-05

2. A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLC;Scientific Reports;2024-09-01

3. Neoadjuvant low-dose radiotherapy plus durvalumab and chemotherapy for potentially resectable stage III NSCLC: A phase Ib dose-escalation study;Radiotherapy and Oncology;2024-07

4. Green synthesis and characterization of α-Mn2O3 nanoparticles for antibacterial activity and efficient visible-light photocatalysis;Scientific Reports;2024-03-21

5. Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity;Scientific Reports;2024-03-21